Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Mar 12;8(5):1328-1329.
doi: 10.1182/bloodadvances.2023012523.

A sweet deal: blocking NMDAR for safer t-PA in diabetes

Affiliations
Editorial

A sweet deal: blocking NMDAR for safer t-PA in diabetes

Frederik Denorme. Blood Adv. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest disclosure: F.D. declares no competing financial interests.

Comment on

References

    1. Lebrun F, Levard D, Lemarchand E, et al. Improving stroke outcomes in hyperglycemic mice by modulating tPA/NMDAR signaling to reduce inflammation and hemorrhages. Blood Adv. 2024;8(5):1330–1344. - PMC - PubMed
    1. Seillier C, Lesept F, Toutirais O, et al. Targeting NMDA receptors at the neurovascular unit: past and future treatments for central nervous system Diseases. Int J Mol Sci. 2022;23(18) - PMC - PubMed
    1. Kruyt ND, Biessels GJ, Devries JH, Roos YB. Hyperglycemia in acute ischemic stroke: pathophysiology and clinical management. Nat Rev Neurol. 2010;6(3):145–155. - PubMed
    1. Desilles J-P, Meseguer E, Labreuche J, et al. Diabetes mellitus, admission glucose, and outcomes after stroke thrombolysis: a registry and systematic review. Stroke. 2013;44(7):1915–1923. - PubMed
    1. Johnston KC, Bruno A, Pauls Q, et al. Intensive vs standard treatment of hyperglycemia and functional outcome in patients with acute ischemic stroke: the SHINE Randomized Clinical Trial. JAMA. 2019;322(4):326–335. - PMC - PubMed